{"url_path":"/sec/sgmt/8-k/2026-04-27/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1400118/0001104659-26-048971-index.html","accession_number":"0001104659-26-048971","cik":"0001400118","ticker":"SGMT","issuer_name":"Sagimet Biosciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1400118/0001104659-26-048971-index.html","primary_entity_key":"0001400118","primary_entity_name":"Sagimet Biosciences Inc."},"word_count":44,"has_tables":true,"body_markdown":"**Item 8.01**\n**Other Events.**\n\n \n\nOn April 27, 2026, the Company issued\na press release announcing certain strategic and corporate updates. The full text of the press release is filed as Exhibit 99.2 to\nthis Current Report on Form 8-K and incorporated herein by reference."}